Chicago Cancer Navigation Project

描述（由申请人提供）： 本申请的目的是为伊利诺伊州芝加哥的低收入患者开发患者导航干预，这些患者需要对前列腺、结直肠、乳腺和宫颈的阳性癌症筛查试验进行随访护理。我们计划创建一个病人导航程序，与个人，谁虽然贫穷，有保证的财政获得后续护理后，积极的筛查测试报告接口。退伍军人将通过杰西布朗芝加哥VA和附属湖滨社区门诊诊所（VA）卫生系统（前列腺癌和结直肠癌）接受后续护理，在Access社区卫生网络（ACCESS）接受护理的患者将通过医疗补助保险计划（乳腺癌和宫颈癌，作为伊利诺伊州乳腺癌和宫颈癌治疗法案的一部分）接受后续护理。拟议中的患者导航器将与退伍军人健康管理局（湖滨和西区地点）和Access（一个公共卫生服务指定的330个联邦合格健康中心组织）紧密结合。该计划是建立在一个预先存在的导航程序（从美国癌症协会/疾病控制中心资助的种族和民族的方法社区健康（REACH）2010年项目）。2003年，在杰西·布朗退伍军人医疗中心，每年有150名退伍军人被诊断出患有前列腺癌，120名被诊断出患有结肠直肠癌，而在ACCESS中心，有152名妇女被诊断出患有乳腺癌，259名妇女被诊断出患有宫颈癌。通过该计划，预计将为9400名前列腺、结直肠、宫颈和乳腺筛查异常的人提供导航。本申请的具体目的是：1）与之前的性能和常规护理对照部位相比，增加导航介入部位中进行诊断评价的患者比例; 2）对于接受随访诊断评估以改善异常筛查和最终随访之间诊断解决的平均时间的患者-与以前的性能和通常的护理对照部位相比，

DESCRIPTION (provided by applicant): The purpose of this application is to develop a patient navigation intervention for lower income patients in Chicago, Illinois, who need follow-up care for positive cancer screening tests of the prostate, colorectum, breast and cervix. We plan to create a patient navigator program, which interfaces with individuals, who although poor, have guaranteed financial access to follow-up care after a positive screening test is reported. Veterans will receive follow-up care through the Jesse Brown Chicago VA and affiliated Lakeside Community Based Outpatient Clinic (VA) health system (for prostate and colorectal cancer) and patients who receive care at Access Community Health Network (ACCESS) will receive follow-up care through the Medicaid insurance program (for breast and cervical cancer, as part of the Illinois Breast and Cervical Cancer Treatment Act). The proposed patient navigator will be closely integrated with the Veterans' Health Administration (Lakeside and Westside locations) and ACCESS, a Public Health Service-designated 330 Federally Qualified Health Center organization. This program is built, in part, upon a pre-existing navigator program (from the American Cancer Society / Centers for Disease Control funded Racial and Ethnic Approaches to Community Health (REACH) 2010 project). In 2003, 150 Veterans were diagnosed with prostate cancer and 120 diagnosed with colorectal cancer each year at the Jesse Brown VA medical center, while 152 women with breast cancer and 259 women with cervical cancer were identified at ACCESS. Through this program it is estimated that 9400 persons with abnormal screening tests for prostate, colorectal, cervical and breast will be navigated. The specific aims of this application are to: 1) increase the proportion of patients with diagnostic evaluations amongst the navigator interventions sites as compared to both previous performance and the usual care control sites; 2) for patients who do get follow-up diagnostic evaluations to improve mean time to a diagnostic resolution between abnormal screening and definitive follow-up for the intervention sites as compared to both previous performance and to the usual care control sites